Results 211 to 220 of about 326,497 (313)
Some of the next articles are maybe not open access.

[Hemodynamic aspects in therapy with anti-arrhythmia agents].

Deutsche Medizinische Wochenschrift, 2008
B. Lüderitz
semanticscholar   +1 more source

Adenosin als Antiarrhythmikum

DMW - Deutsche Medizinische Wochenschrift, 2009
Scheininger Mj, Wehling M
openaire   +3 more sources

[Hemodynamic effects of class-I and class-III anti-arrhythmia agents].

Deutsche Medizinische Wochenschrift, 2008
G. Schmidt, P. Honerjäger, T. Niesel
semanticscholar   +1 more source

Proarrhythmische Effekte von Antiarrhythmika

DMW - Deutsche Medizinische Wochenschrift, 2008
Stefan H. Hohnloser, Philip J. Podrid
openaire   +3 more sources

[Combination therapy with anti-arrhythmia agents].

open access: closedMedizinische Klinik (Munich, Germany : 1983), 1992
B, Lüderitz, W, Jung, M, Manz
openaire   +2 more sources

[The cardiotoxic properties of anti-arrhythmia agents].

Eksperimental'naia i klinicheskaia farmakologiia, 1997
Experiments were conducted on cats to study the cardiotoxic and arrhythmogenic properties of some antiarrhythmic agents in continuous intravenous infusion in doses multiple of the dose which causes an antiarrhythmic effect on an acontic model of arrhythmia in rats in 50% of cases.
A A, Spasov, N A, Gurova
openaire   +1 more source

[Arrhythmogenic effects of anti-arrhythmia agents].

Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1987
Arrhythmogenic effects appear in 5-22% of all patients. On the basis of a literary investigation on 11,547 patients with 1,114 proarrhythmic effects and of 21 own observations mechanisms, risks and diagnostics of this dangerous side effect are demonstrated.
D, Pfeiffer   +4 more
openaire   +1 more source

[Combined action of anti-arrhythmia agents].

Biulleten' eksperimental'noi biologii i meditsiny, 1991
A significant potentiation of antiarrhythmic effect was observed in 121 dogs with arrhythmias 24 and 48 hours after the coronary artery ligation when the following drugs were combined: N-propylajmaline bromide (1A class) and trimecaine (1B class), quinidine (1A class) and trimecaine, N-propylajmaline bromide and anaprilin (2 class). The potentiation is
E I, Gendenshteĭn   +3 more
openaire   +1 more source

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

Home - About - Disclaimer - Privacy